Harvard Bioscience Stock
Your prediction
Harvard Bioscience Stock
The Harvard Bioscience stock is trending slightly upwards today, with an increase of €0.020 (0.580%) compared to yesterday's price.
Pros and Cons of Harvard Bioscience in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Harvard Bioscience vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Harvard Bioscience | 0.580% | -2.286% | -11.856% | -35.472% | -28.452% | -45.714% | 52.271% |
| MicroVision Inc | -24.130% | 1.417% | -5.183% | -36.845% | -41.033% | -87.151% | 90.679% |
| Fonar Corp. New | - | 9.459% | -5.263% | 8.725% | -8.475% | 11.724% | -8.753% |
| Allscripts Healthcare | 5.800% | 0.000% | -1.351% | -31.132% | -21.081% | -44.275% | -19.078% |
Comments
Harvard Bioscience, Inc. (NASDAQ: HBIO) had its price target raised by analysts at Benchmark Co. from $3.00 to $4.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HBIO provided by MarketBeat
News
Social Security Has a Big Immigration Problem -- but It's Probably Not What You Think
A recent survey conducted by the Nationwide Retirement Institute revealed that retirees view inflation and potential Social Security benefit cuts as their biggest concerns. And the Harvard
